FDA's review process under investigation

AP/Yahoo News, March 5, 2008
The Government Accountability Office is investigating whether the Food and Drug Administration's drug-review process cleared two blockbuster medications without sufficient proof of their safety or effectiveness. Sen. Charles Grassley suggested the investigation after recent studies showed the drugs may not lower the risk of heart attack and artery-clogging plaque, as assumed by millions of patients and doctors.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.